Notebook

Nobel laureate David Baltimore will assume the presidency of the California Institute of Technology this fall. Baltimore, 59, tells The Scientist he is leaving his post as a professor of molecular biology and immunology at the Massachusetts Institute of Technology, where he has been since 1994, because Caltech is "one of the premier scientific organizations in the world." Baltimore's tenure as president of Rockefeller University in New York lasted just 18 months; he resigned in late 1991 in the

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Nobel laureate David Baltimore will assume the presidency of the California Institute of Technology this fall. Baltimore, 59, tells The Scientist he is leaving his post as a professor of molecular biology and immunology at the Massachusetts Institute of Technology, where he has been since 1994, because Caltech is "one of the premier scientific organizations in the world." Baltimore's tenure as president of Rockefeller University in New York lasted just 18 months; he resigned in late 1991 in the midst of a furor caused by a paper (D. Weaver et al., Cell, 45:247-59, 1986) he coauthored with Thereza Imanishi-Kari, who was accused of falsifying data to obtain better results. Baltimore, who was not accused of wrongdoing, nevertheless became a lightning rod for controversy and a subject of congressional hearings for defending Imanishi-Kari, who was later cleared by an appeals panel of the U.S. Department of Health and Human Services (B. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery